Heparin-Induced Thrombocytopenia in a Nonthrombocytopenic Patient With Toxic Epidermal Necrolysis Causing Fatal Outcome: Is HIT Still a HIT?

被引:1
|
作者
Busche, Marc Nicolai [1 ]
Peters, Tina [1 ]
Knobloch, Karsten [1 ]
Vogt, Peter Maria [1 ]
Rennekampff, Hans-Oliver [1 ]
机构
[1] Hannover Med Sch, Dept Plast Hand & Reconstruct Surg, Burn Ctr, D-30625 Hannover, Germany
关键词
MOLECULAR-WEIGHT HEPARIN; ARGATROBAN ANTICOAGULATION; UNFRACTIONATED HEPARIN; ANTIBODIES; THROMBOSIS; PLATELET-FACTOR-4; REPLACEMENT; THERAPY; RISK;
D O I
10.1097/BCR.0b013e3181ac05bf
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
The definition of heparin-induced thrombocytopenia (HIT) has been modified over time; however, most definitions require a relative or absolute thrombocytopenia after exposure to heparin. Therefore, routine platelet count monitoring has been recommended for screening. We present the case of a 26-year-old male patient with toxic epidermal necrolysis who developed a rapid and fatal clinical presentation of HIT, without thrombocytopenia at the time of diagnosis. Because our patient did not present a relative or absolute thrombocytopenia at the time of serological and clinical confirmation of HIT, routine platelet count monitoring failed to detect HIT in our patient. As a result of the here presented case of rapid and fatal HIT, it may be prudent to consider if thrombocytopenia, although it is still a common and important hallmark of HIT, should be an absolute requirement for the definition of HIT. In cases of HIT without any thrombocytopenia, screening for HIT antibodies may be the only way to detect HIT early enough to react. Because there is a high incidence of HIT antibodies in the general population, which are not always associated with HIT, screening for HIT antibodies cannot be recommended for every patient receiving heparin. However, prospective studies may be useful in determining if routine screening for HIT antibodies can decrease the morbidity and mortality of HIT in critically ill patients receiving therapeutic doses of unfractionated heparin on the intensive care unit. (J Burn Care Res 2009;30: 747-751)
引用
收藏
页码:747 / 751
页数:5
相关论文
共 50 条
  • [31] Treatment and outcomes of heparin-induced thrombocytopenia (HIT) in patients with neoplasm, a case series
    Lai, Chieh Min Benjamin
    Smith, Tyler
    Lee, Agnes Yuet Ying
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2021, 51 (03) : 725 - 733
  • [32] Pathomorphological aspects of heparin-induced thrombocytopenia II (HIT-II syndrome)
    Hermanns, B
    Janssens, U
    Handt, S
    Füzesi, L
    VIRCHOWS ARCHIV-AN INTERNATIONAL JOURNAL OF PATHOLOGY, 1998, 432 (06): : 541 - 546
  • [33] Performance of 4T score and heparin-platelet factor 4 antibody in the diagnosis of heparin-induced thrombocytopenia (HIT) in cancer
    Wong, Myra
    Oo, Thein Hlaing
    Qiao, Wei
    Garg, Naveen
    Rojas-Hernandez, Cristhiam M.
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2017, 44 (02) : 261 - 266
  • [34] Combination of two complementary automated rapid assays for diagnosis of heparin-induced thrombocytopenia (HIT)
    Warkentin, Theodore E.
    Sheppard, Jo-Ann I.
    Smith, James W.
    Li, Na
    Moore, Jane C.
    Arnold, Donald M.
    Nazy, Ishac
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2020, 18 (06) : 1435 - 1446
  • [35] The importance and incidence of heparin-induced thrombocytopenia (HIT) type II.: A prospective study
    Mahlfeld, K
    Böck, M
    Franke, J
    Meinecke, I
    Schaeper, O
    Kayser, R
    Grasshoff, H
    ZENTRALBLATT FUR CHIRURGIE, 2001, 126 (01): : 39 - 43
  • [36] Prospective evaluation of automatized PF4/heparin immunoassays HemosIL HIT-ab (PF4-H) for the diagnosis of heparin-induced thrombocytopenia
    Jourdy, Y.
    Nougier, C.
    Rugeri, L.
    Bordet, J. C.
    Sobas, F.
    Negrier, C.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2015, 37 (02) : 244 - 252
  • [37] The HIT Expert Probability (HEP) Score: a novel pre-test probability model for heparin-induced thrombocytopenia based on broad expert opinion
    Cuker, A.
    Arepally, G.
    Crowther, M. A.
    Rice, L.
    Datko, F.
    Hook, K.
    Propert, K. J.
    Kuter, D. J.
    Ortel, T. L.
    Konkle, B. A.
    Cines, D. B.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2010, 8 (12) : 2642 - 2650
  • [38] Ilio-femoral by-pass in a patient with heparin-induced thrombocytopaenia (HIT)
    Papas, T. T.
    Kotsikoris, I
    Maras, D.
    Bessias, N.
    HIPPOKRATIA, 2012, 16 (04) : 389 - 389
  • [39] Clinical validation of immunoassay HemosIL® AcuStar HIT-IgG (PF4-H) in the diagnosis of Heparin-induced thrombocytopenia
    Marashi-Sabouni, Zeina
    Vayne, Caroline
    Ibrahim-Kosta, Manal
    Guidon, Catherine
    Loundou, Anderson
    Guery, Eve Anne
    Morange, Pierre-Emmanuel
    Camoin-Jau, Laurence
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2021, 52 (02) : 601 - 609
  • [40] Experts' opinion or the serotonin release assay as a gold standard for the diagnosis of heparin-induced thrombocytopenia (HIT)?
    Tardy, B.
    Presles, E.
    Akrour, M.
    De Maistre, E.
    Lecompte, T.
    Tardy-Poncet, B.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 (08) : 1667 - 1669